Overview

The Repatriation Medical Authority Instrument No. 66 of 2011, enacted under the Veterans’ Entitlements Act 1986, was introduced to address and finalise an investigation into malignant neoplasm of the stomach, specifically concerning the impact of ionising radiation on this condition. This legislative instrument, determined by the Repatriation Medical Authority, aims to amend the existing Statement of Principles concerning the stomach cancer, refining the criteria under which veterans may claim compensation for this condition. The Authority conducted an investigation and invited submissions from relevant organisations and experts, though no submissions were received during the process. This instrument not only updates the criteria for eligibility but also specifies the effective date of these amendments in accordance with the Legislative Instruments Act 2003. The Authority's decision is intended to provide clarity and updated medical considerations regarding the conditions under which veterans can claim for this specific health issue.

Scope and Application

The Repatriation Medical Authority Instrument No. 66 of 2011 amends Statement of Principles Instrument No. 8 of 2003 concerning malignant neoplasm of the stomach, applying to the provisions of the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. This legislative instrument specifically targets veterans and service personnel who have developed malignant neoplasm of the stomach, potentially linking their condition to ionising radiation. The Authority's decision follows an investigation initiated through public notices in the Government Notices Gazettes of 1 September 2010 and 3 November 2010, inviting submissions from relevant parties, although none were received. The amendments redefine and replace certain factors and definitions, effective as specified under the Legislative Instruments Act 2003, thus impacting the criteria for entitlement to certain benefits and compensations related to the condition.

Key Provisions

The main operative sections of this Instrument involve amendments to Statement of Principles Instrument No. 8 of 2003 regarding malignant neoplasm of the stomach, which is addressed in section 2 of the explanatory notes. The Authority has introduced a new factor concerning "ionising radiation" to replace existing factor 5(a)(ii), and has deleted factor 5(a)(iii) as it is now covered by the new factor. Furthermore, the definition of "cumulative equivalent dose" has been revised, and the definitions of "a course of therapeutic radiation" and "atomic radiation" have been removed from clause 8. These changes are aimed at refining the criteria for assessing claims related to malignant neoplasm of the stomach under the Veterans' Entitlements Act 1986 (VEA) and the Military Rehabilitation and Compensation Act 2004. The obligations and requirements imposed by this Act primarily involve the Repatriation Medical Authority (the Authority), which is responsible for determining and finalising the investigation into malignant neoplasm of the stomach. The Authority must ensure that its determinations are in accordance with the legislative provisions of the VEA and the Legislative Instruments Act 2003. Additionally, the Authority is required to advertise its intention to investigate the condition in the Government Notices Gazettes and to invite submissions from relevant stakeholders, such as the Repatriation Commission and organisations representing veterans and their dependants. While the Authority circulated notices of intention to investigate, it is noted that no submissions were received for consideration during the investigation. In terms of offences, penalties, or consequences for breach, the explanatory notes do not explicitly mention any specific offences or penalties related to the failure to comply with the provisions of this Instrument. However, it is important to note that the Authority's determinations and amendments to the Statement of Principles are subject to the legislative framework of the VEA and the Military Rehabilitation and Compensation Act 2004. Any failure to adhere to the legislative requirements or to properly investigate and determine the conditions related to malignant neoplasm of the stomach could potentially lead to legal challenges or disputes regarding the validity of the Authority's decisions. The consequences of such disputes could include the need for further investigation, reconsideration of the Authority's determinations, or even potential legal action by affected parties. The Instrument also specifies a date of effect for the amendment in accordance with subsection 12(1)(a) of the Legislative Instruments Act 2003. This means that the changes introduced by the Instrument will take effect on a specific date, as determined by the Authority in accordance with the legislative provisions. This date of effect is crucial for ensuring that the amendments are implemented in a timely and orderly manner, and that affected parties are aware of the changes and can adjust their claims and entitlements accordingly. The Authority must ensure that the date of effect is clearly communicated to relevant stakeholders, and that the transition to the new criteria is as smooth as possible.